# Drug-eluting Beads Bronchial Arterial Chemoembolization in Stage II-III Non-small-cell Lung Cancer Patients Failed, Refused or Ineligible to Receive Standard Treatments

> **NCT04825925** · NA · UNKNOWN · sponsor: **Tianjin Medical University Cancer Institute and Hospital** · enrollment: 60 (estimated)

## Conditions studied

- Carcinoma, Non-Small-Cell Lung

## Interventions

- **DEVICE:** DEB-BACE(Drug-eluting beads bronchial arterial chemoembolization)

## Key facts

- **NCT ID:** NCT04825925
- **Lead sponsor:** Tianjin Medical University Cancer Institute and Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-05-01
- **Primary completion:** 2024-05-01
- **Final completion:** 2024-10-01
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2021-04-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04825925

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04825925, "Drug-eluting Beads Bronchial Arterial Chemoembolization in Stage II-III Non-small-cell Lung Cancer Patients Failed, Refused or Ineligible to Receive Standard Treatments". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT04825925. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*